Drug
Edp 514
Edp 514: highest development phase Phase 1, developed by Enanta Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Enanta Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| EDP-514 NCT04008004 | Phase 1 | Chronic HBV Infection |
| EDP-514 NCT04783753 | Phase 1 | Hepatitis B |
Latest
No recent events.
Follow Edp 514 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.